In March, we added 126 citations in DIDB, including 59 in vitro (with 19 articles published in March 2026) and 67 in vivo articles (with 37 articles published in March 2026).
3 NDAs and 1 BLA approved by the FDA in January and February 2026, including copper histidinate (ZYCUBO), difamilast (ADQUEY), milsaperidone (BYSANTI), and pegzilarginase (LOARGYS), were also curated in DIDB.
You can check the citations that are recently published and entered in DIDB and all the NDAs/BLAs in DIDB.
As always, feel free to contact us if you have any questions or comments.